Wegovy Delayed-Onset Side Effects: What Happens Weeks or Months After Starting
The Wegovy label reports gallbladder disease, pancreatitis, kidney injury and hair loss in trials of up to 68 weeks. It does not say when each begins.
Wegovy: Side Effects
5 source-based articles maintained by the HealthRX.com Editorial Team.
5articles
2topic areas covered
Jul 10, 2025latest review
Wegovy: Side Effects library
Showing 5 of 5 clinical reviews.
Wegovy Side Effects Severity Distribution by Patient Phenotype
A clinical breakdown of Wegovy (semaglutide 2.4 mg) adverse events by severity and patient phenotype, citing STEP trials, FDA labeling, and FAERS post-market data to help clinicians and patients understand who is most at risk.
Wegovy Side Effects: Incidence Rates Across Clinical Trials
A data-driven breakdown of Wegovy (semaglutide 2.4 mg) side effect incidence rates from STEP trials, FDA labeling, FAERS reports, and post-market literature.
Wegovy Side Effects: Rare but Serious Adverse Events You Need to Know
A clinically detailed guide to the rare but serious adverse events associated with Wegovy (semaglutide 2.4 mg), covering thyroid tumors, pancreatitis, gallbladder disease, kidney injury, suicidality, and more, with trial data and FDA label citations.
Wegovy Side Effects: Withdrawal and Discontinuation Syndrome Explained
What happens when you stop Wegovy? Learn about weight regain, rebound hunger, GI symptoms, and the clinical evidence on semaglutide discontinuation syndrome from named trials and the FDA label.